Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIPOCONTROL

K-Number: K090754 · 2011-01-21

Decision Date2011-01-21
Product CodeORK
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

LIPOCONTROL is the device name listed in this FDA 510(k) record. The listed applicant is Osyris Medical. It received FDA 510(k) clearance on 2011-01-21 under 510(k) number K090754. The device is classified under product code ORK. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIPOCONTROL?

LIPOCONTROL is a medical device that received FDA 510(k) clearance on 2011-01-21. The listed applicant is Osyris Medical. The 510(k) number is K090754.

When did LIPOCONTROL receive FDA 510(k) clearance?

LIPOCONTROL received FDA 510(k) clearance on 2011-01-21, under 510(k) number K090754.

Who is the listed applicant for LIPOCONTROL?

The FDA 510(k) record lists Osyris Medical as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIPOCONTROL?

The FDA product code for LIPOCONTROL is ORK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑